CTRI/2022/11/047214已完成4 期
A Study on Shishira Ritu and evaluation of effect of Pathya Kalpana (Tila Urada Guda Ghrita)
Rajiv Gandhi Government post graduate ayurvedic college and hospital paprola distt kangra HP 1761150 个研究点目标入组 23 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 23
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Volunteers willing for trial.
- •Age group 20 - 60 years.
- •Apparently healthy volunteers with clinical features of Vriddha Agni assessed as per survey.
- •Written consent of the volunteers will be obtained before inclusion in the trial.
排除标准
- •Volunteers not willing for the trial.
- •Volunteers below 20 years and above 60 years.
- •Volunteers having any associated chronic ailments like Diabetes Mellitus, Cardiac disorder, Dyslipidaemia, Renal disorder, Alcoholic liver disease.
- •Pregnant and Lactating mothers.
研究者
相似试验
尚未招募
4 期
Study on Sharada Ritu(September to November),to evaluate the effect of Virechana Karma on Pitta prakop during Sharada Ritu.CTRI/2022/07/044373Rajiv Gandhi Government Post Graduate Ayurvedic College
尚未招募
4 期
To find out Rejuvenative effect of Haritaki churna with Saindhav namak with lukewarm water in rainy seasoCTRI/2023/05/052932RGGPG Ayurvedic College and Hospital Paprola District Kangra
尚未招募
Unknown
pain management by siravedh chikitsa In VataraktaCTRI/2024/07/070686DR MAYURI DINESH THAKRE
进行中（未招募）
不适用
A Multicenter Study to Evaluate the Effect of Rituximab (IDEC-102) on Primary Humoral Response, Recall Response, and Maintenance of Acquired Immunity to Specific Antigens - 102-12Relapsed (maximum of 5 relapses) or refractory, low-grade or follicular, CD20+, B-cell Non-Hodgkin’s Lymphoma (NHL)EUCTR2004-004774-85-LTBiogen Idec Inc160
进行中（未招募）
不适用
A Multicenter Study to Evaluate the Effect of Rituximab (IDEC-102) on Primary Humoral Response, Recall Response, and Maintenance of Acquired Immunity to Specific Antigens - 102-12Relapsed (maximum of 5 relapses) or refractory, low-grade or follicular, CD20+, B-cell Non-Hodgkin’s Lymphoma (NHL)EUCTR2004-004774-85-DEBiogen Idec Inc160